Syncom Formulations (India) balance sheet

As of Mar 2026

Total assets: ₹534cr+29.2% on Mar 2025
Shareholders' equity: ₹415cr+21.3% on Mar 2025
Total debt: ₹1.5cr−67.8% on Mar 2025
Cash and investments: ₹112cr+24.2% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Non-current assets
	89.8	77.5	72.3	43.2
	0.0	0.0	0.0	25.6
	93.3	47.3	47.3	47.3
	0.4	0.0	0.1	0.2
	2.5	3.6	2.5	1.8
	16.1	14.0	7.4	76.2
	18.7	17.6	9.9	78.1
	1.3	0.8	0.2	1.8
	203	143	130	196
Current assets
	62.9	41.3	21.1	21.2
	107	89.2	63.7	62.3
	111	108	103	75.5
	5.1	0.7	63.4	0.9
	1.2	0.0	4.5	7.8
	7.0	5.4	4.3	2.8
	3.8	3.5	4.1	3.7
	234	206	243	153
	33.3	22.2	10.4	7.6
	330	270	275	182
	534	413	405	378
Equity
	94.0	94.0	94.0	94.0
	321	248	194	162
	415	342	288	256
	415	342	288	256
Liabilities
	1.6	1.3	1.7	1.5
	1.6	1.3	1.7	1.5
	5.4	4.2	3.3	2.7
	8.1	6.3	5.0	4.4
	0.0	0.0	0.0	0.0
	15.1	11.8	10.0	8.7
	1.5	4.6	72.5	83.2
	74.4	42.8	24.1	20.4
	2.2	2.1	2.1	2.0
	78.0	49.5	98.8	106
	6.4	4.2	3.6	2.6
	19.3	5.6	4.1	4.9
	104	59.3	107	113
	119	71.1	117	122
	534	413	405	378
Trade payables — MSME split
	5.9	22.8	—	—
	68.5	20.0	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SYNCOMF₹20.33

Syncom Formulations (India) Limited

· Pharma & Health

₹ CrorePeersHESTERBIO NGLFINE WINDLAS JAGSNPHARMAMRUTANJAN INDOCO SAIPARENTMcap ₹1,911 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	43.2	72.3	77.5	89.8	89.8
+ Capital Work-in-Progress	25.6	0.0	0.0	0.0	0.0
+ Investment Property	47.3	47.3	47.3	93.3	93.3
+ Other Intangibles	0.2	0.1	0.0	0.4	0.4
+ Non-current Investments	1.8	2.5	3.6	2.5	2.5
+ Other Non-current Financial Assets	76.2	7.4	14.0	16.1	16.1
Non-current Financial Assets	78.1	9.9	17.6	18.7	18.7
+ Other Non-current Assets	1.8	0.2	0.8	1.3	1.3
Total Non-current Assets	196.1	129.9	143.3	203.5	203.5
Current Assets
+ Inventories	21.2	21.1	41.3	62.9	62.9
+ Current Investments	62.3	63.7	89.2	106.5	106.5
+ Trade Receivables	75.5	103.3	107.5	110.5	110.5
+ Cash & Cash Equivalents	0.9	63.4	0.7	5.1	5.1
+ Other Bank Balances	7.8	4.5	0.0	1.2	1.2
+ Short-term Loans	2.8	4.3	5.4	7.0	7.0
+ Other Current Financial Assets	3.7	4.1	3.5	3.8	3.8
Current Financial Assets	152.9	243.3	206.4	234.2	234.2
+ Other Current Assets	7.6	10.4	22.2	33.3	33.3
Total Current Assets	181.7	274.8	270.0	330.4	330.4
Total Assets	377.8	404.7	413.3	533.8	533.8
Equity
+ Equity Share Capital	94.0	94.0	94.0	94.0	94.0
+ Other Equity / Reserves	162.0	194.1	248.2	321.0	321.0
Equity — Owners of Parent	256.0	288.1	342.2	415.0	415.0
Total Equity	256.0	288.1	342.2	415.0	415.0
Liabilities
+ Other Non-current Financial Liab	1.5	1.7	1.3	1.6	1.6
Non-current Financial Liabilities	1.5	1.7	1.3	1.6	1.6
+ Provisions — Non-current	2.7	3.3	4.2	5.4	5.4
+ Deferred Tax Liabilities	4.4	5.0	6.3	8.1	8.1
+ Other Non-current Liabilities	0.0	0.0	0.0	0.0	0.0
Non-current Liabilities	8.7	10.0	11.8	15.1	15.1
+ Borrowings — Current	83.2	72.5	4.6	1.5	1.5
+ Trade Payables	20.4	24.1	42.8	74.4	74.4
+ Other Current Financial Liab	2.0	2.1	2.1	2.2	2.2
Current Financial Liabilities	105.7	98.8	49.5	78.0	78.0
+ Provisions — Current	2.6	3.6	4.2	6.4	6.4
+ Other Current Liabilities	4.9	4.1	5.6	19.3	19.3
Current Liabilities	113.2	106.5	59.3	103.7	103.7
Total Liabilities	121.8	116.5	71.1	118.9	118.9
Total Equity & Liabilities	377.8	404.7	413.3	533.8	533.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	22.8	5.9	5.9
+ Dues to Other Creditors — Current	—	—	20.0	68.5	68.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.